- Report
- June 2026
- 322 Pages
Global
From €5252EUR$5,850USD£4,540GBP
- Report
- June 2026
- 200 Pages
Global
From €5252EUR$5,850USD£4,540GBP
- Report
- June 2026
- 219 Pages
Global
From €5252EUR$5,850USD£4,540GBP
- Report
- June 2026
- 263 Pages
Global
From €5252EUR$5,850USD£4,540GBP
- Report
- June 2026
- 295 Pages
Global
From €5252EUR$5,850USD£4,540GBP
- Report
- June 2026
- 504 Pages
Global
From €5252EUR$5,850USD£4,540GBP
- Report
- June 2026
- 191 Pages
Global
From €5252EUR$5,850USD£4,540GBP
- Report
- June 2026
- 350 Pages
Global
From €5252EUR$5,850USD£4,540GBP
- Report
- June 2026
- 368 Pages
Global
From €5252EUR$5,850USD£4,540GBP
- Report
- June 2026
- 462 Pages
Global
From €5252EUR$5,850USD£4,540GBP
- Report
- January 2026
- 181 Pages
Global
From €3183EUR$3,545USD£2,751GBP
€3537EUR$3,939USD£3,057GBP
- Report
- January 2026
- 193 Pages
Global
From €3183EUR$3,545USD£2,751GBP
€3537EUR$3,939USD£3,057GBP
- Report
- January 2026
- 187 Pages
Global
From €3183EUR$3,545USD£2,751GBP
€3537EUR$3,939USD£3,057GBP
- Report
- November 2025
- 181 Pages
Global
From €3183EUR$3,545USD£2,751GBP
€3537EUR$3,939USD£3,057GBP
- Report
- January 2026
- 186 Pages
Global
From €4040EUR$4,500USD£3,492GBP
- Report
- May 2026
- 250 Pages
Global
From €4031EUR$4,490USD£3,484GBP
- Report
- February 2026
- 250 Pages
Global
From €4031EUR$4,490USD£3,484GBP
- Report
- February 2026
- 250 Pages
Global
From €4031EUR$4,490USD£3,484GBP
- Report
- February 2026
- 250 Pages
Global
From €4031EUR$4,490USD£3,484GBP
- Report
- February 2026
- 250 Pages
Global
From €4031EUR$4,490USD£3,484GBP

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection.
The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more